Ensysce Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of solutions for severe pain relief while reducing the fear of and the potential for misuse and overdose. The firm's Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms are in the process of developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. The company was founded in April 2003 and is headquartered in La Jolla, CA.
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Ensysce Biosciences Inc market cap is $7M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Ensysce Biosciences Inc 52 week high is $1.85 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Ensysce Biosciences Inc 52 week low is $0.23 as of November 22, 2026.
Ensysce Biosciences Inc stock price today is $0.36.
Ensysce Biosciences Inc stock price yesterday was $0.3606.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Ensysce Biosciences Inc's P/E ratio is -0.06.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Ensysce Biosciences Inc P/B ratio is 0.2553.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Ensysce Biosciences Inc 50-day moving average is $0.4354.